Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder...

Area of Science:

• Urology
• Oncology

Background:

• Pelvic node-positive, non-metastatic bladder cancer is a distinct clinical entity.
• Outcomes bridge bladder-confined muscle-invasive and metastatic bladder cancer.
• Current guidelines acknowledge unique management needs.

Purpose of the Study:

• To review key considerations for managing pelvic node-positive bladder cancer.
• To discuss current treatment options and future directions.

Main Methods:

• Literature review of current evidence and guidelines.
• Discussion of treatment modalities and emerging therapies.

Main Results:

• No definitive standard of care exists for this patient population.
• Treatment options include systemic therapy, neoadjuvant chemotherapy with radical cystectomy, or trimodality therapy.
• Immunotherapy integration is under investigation.

Conclusions:

• Management of pelvic node-positive bladder cancer requires careful consideration of distinct clinical factors.
• Further research is needed to establish optimal treatment paradigms, including immunotherapy.